Cold Agglutinin Disease News

  • Home
  • Cold Agglutinin Disease News

Cold Agglutinin Disease News Cold Agglutinin Disease News is a digital platform providing daily updates on research, science and
(21)

CAD treatment decisions need to be made on a case-by-case basis, considering patients' specific needs, per a review stud...
27/06/2024

CAD treatment decisions need to be made on a case-by-case basis, considering patients' specific needs, per a review study. https://buff.ly/45L10P4

Columnist Mary Lott's days with cold agglutinin disease have helped her learn how to practice patience and anticipation....
24/06/2024

Columnist Mary Lott's days with cold agglutinin disease have helped her learn how to practice patience and anticipation. https://buff.ly/3RB24yX

Obinutuzumab was an effective treatment for controlling primary cold agglutinin disease (CAD) in a woman in her 80s, per...
20/06/2024

Obinutuzumab was an effective treatment for controlling primary cold agglutinin disease (CAD) in a woman in her 80s, per a case report. https://buff.ly/4c8zgWO

Columnist Mary Lott's recent trip from Indonesia to the U.S. taught her some valuable lessons about how to travel with a...
17/06/2024

Columnist Mary Lott's recent trip from Indonesia to the U.S. taught her some valuable lessons about how to travel with a chronic illness. https://buff.ly/4cnPB9R

The CAD treatment Enjaymo (sutimlimab) needs to be about 80% cheaper to meet commonly-accepted thresholds for cost-effec...
13/06/2024

The CAD treatment Enjaymo (sutimlimab) needs to be about 80% cheaper to meet commonly-accepted thresholds for cost-effectiveness, a study says. https://buff.ly/4c0SUEg

Both columnist Mary Lott and her motorcycle are growing old, requiring regular evaluations and treatments to keep them "...
10/06/2024

Both columnist Mary Lott and her motorcycle are growing old, requiring regular evaluations and treatments to keep them "running smoothly." https://buff.ly/3yXDxxN

An accurate diagnosis of cold agglutinin disease requires a step-by-step process to identify the underlying cause, a rep...
06/06/2024

An accurate diagnosis of cold agglutinin disease requires a step-by-step process to identify the underlying cause, a report says. https://buff.ly/3X79lKE

Living with CAD can result in many frustrating scenarios, says columnist Mary Lott. Here are her most common complaints....
03/06/2024

Living with CAD can result in many frustrating scenarios, says columnist Mary Lott. Here are her most common complaints. https://buff.ly/4bIR8ay

Vermont Governor Phil Scott has signed into law a bill that improves access to the right medication at the right time am...
30/05/2024

Vermont Governor Phil Scott has signed into law a bill that improves access to the right medication at the right time among insured patients. https://buff.ly/3WWvhIm

Columnist Mary Lott compares her treatment and care to the contents of a slingshot, a modest weapon that took down a mig...
27/05/2024

Columnist Mary Lott compares her treatment and care to the contents of a slingshot, a modest weapon that took down a mighty foe. https://buff.ly/3KDfBCB

A third of adults with severe AIHA, conditions that include cold agglutinin disease, respond to IVIG therapy after seven...
23/05/2024

A third of adults with severe AIHA, conditions that include cold agglutinin disease, respond to IVIG therapy after seven days, a study found. https://buff.ly/3yuuyEb

Cold agglutinin disease can be physically limiting, says columnist Mary Lott, but she's rising above thanks to other sou...
20/05/2024

Cold agglutinin disease can be physically limiting, says columnist Mary Lott, but she's rising above thanks to other sources of strength. https://buff.ly/3K8UYxF

A high-temperature setting helped prevent red blood cell clumping and cell destruction during plasmapheresis in a man wi...
16/05/2024

A high-temperature setting helped prevent red blood cell clumping and cell destruction during plasmapheresis in a man with secondary CAD. https://buff.ly/4dFFDST

It's a season of saying goodbyes in columnist Mary Lott's life, which makes her strategize to protect her health with gr...
13/05/2024

It's a season of saying goodbyes in columnist Mary Lott's life, which makes her strategize to protect her health with groups or individuals. https://buff.ly/3yaOs6M

A woman with both CAD and myelodysplastic syndrome responded well to treatment with the corticosteroid prednisolone foll...
09/05/2024

A woman with both CAD and myelodysplastic syndrome responded well to treatment with the corticosteroid prednisolone followed by cyclosporine. https://buff.ly/3UzDWxF

Changing careers to a job that is fulfilling, but not physically taxing, is a challenge, but columnist Mary Lott has som...
06/05/2024

Changing careers to a job that is fulfilling, but not physically taxing, is a challenge, but columnist Mary Lott has some ideas. https://buff.ly/3UNB41h

Daratumumab could offer a treatment option for refractory AIHA, including CAD, with more than half of patients in a stud...
02/05/2024

Daratumumab could offer a treatment option for refractory AIHA, including CAD, with more than half of patients in a study responding to it. https://buff.ly/4bka52V

After helping her dog to confront a scary noise, columnist Mary Lott considers the value of facing fears head-on in life...
29/04/2024

After helping her dog to confront a scary noise, columnist Mary Lott considers the value of facing fears head-on in life with CAD. https://buff.ly/4dfpXFJ

To prepare for an annual doctor's appointment, columnist Mary Lott has identified six key issues to discuss, along with ...
22/04/2024

To prepare for an annual doctor's appointment, columnist Mary Lott has identified six key issues to discuss, along with several questions. https://buff.ly/3xWXu7a

A report of cold agglutinin disease secondary to a blood cancer in an elderly woman highlights the potential flaws of a ...
18/04/2024

A report of cold agglutinin disease secondary to a blood cancer in an elderly woman highlights the potential flaws of a direct Coombs test. https://buff.ly/49FXg1K

Columnist Mary Lott offers appreciation to her husband, Mike, who often helps out around the house when Mary is fatigued...
15/04/2024

Columnist Mary Lott offers appreciation to her husband, Mike, who often helps out around the house when Mary is fatigued from CAD. https://buff.ly/3VUTKNL

Children and teens with AIHA responded well to first-line treatment as recommended for adults, a retrospective, single-c...
11/04/2024

Children and teens with AIHA responded well to first-line treatment as recommended for adults, a retrospective, single-center study found. https://buff.ly/3PY2Fdi

Columnist Mary Lott loves using her solar dryer (aka a clothesline) to air out laundry. But she must plan the chore arou...
08/04/2024

Columnist Mary Lott loves using her solar dryer (aka a clothesline) to air out laundry. But she must plan the chore around her need for rest. https://buff.ly/43NeKI5

COVID-19 worsened the symptoms of cold agglutinin disease in a 71-year-old man in whom the autoimmune disease had been s...
04/04/2024

COVID-19 worsened the symptoms of cold agglutinin disease in a 71-year-old man in whom the autoimmune disease had been stable. https://buff.ly/49mvsz9

As heavy rains fall on her home in Indonesia, columnist Mary Lott considers the extra challenges she could face with col...
01/04/2024

As heavy rains fall on her home in Indonesia, columnist Mary Lott considers the extra challenges she could face with cold agglutinin disease. https://buff.ly/4cH7Jwo

Pre-treatments with rituximab and plasma exchange limited complications of cold agglutinin disease (CAD) during surgery,...
20/11/2023

Pre-treatments with rituximab and plasma exchange limited complications of
cold agglutinin disease (CAD) during surgery, a case report shows. Read more: https://bit.ly/3SIf876

Here is this week's most-read article featured on our website! Are you caught up?A bipartisan group is proposing new leg...
18/11/2023

Here is this week's most-read article featured on our website! Are you caught up?

A bipartisan group is proposing new legislation that aims to make it easier for people with rare disorders to access off-label treatments.

https://buff.ly/49xDK8L

COVID-19 led to a severe, mixed form of autoimmune hemolytic anemia (AIHA) in a previously healthy 2-year-old girl in th...
15/11/2023

COVID-19 led to a severe, mixed form of autoimmune hemolytic anemia (AIHA) in a previously healthy 2-year-old girl in the U.S.

https://buff.ly/3QWJX6J

Interpreting lab results without waiting for the doctor when managing CAD can cause unnecessary anxiety, writes columnis...
15/11/2023

Interpreting lab results without waiting for the doctor when managing CAD can cause unnecessary anxiety, writes columnist Mary Lott.

https://buff.ly/47d9iPJ

Cold agglutinin disease (CAD) diagnosis was among the topics in a recent webinar on the disorder. Columnist Mary Lott of...
13/11/2023

Cold agglutinin disease (CAD) diagnosis was among the topics in a recent webinar on the disorder. Columnist Mary Lott offers her takeaways. https://buff.ly/46s5RUd

Address


Website

Alerts

Be the first to know and let us send you an email when Cold Agglutinin Disease News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing

  • Want your business to be the top-listed Media Company?

Share